Evidence-Based Pharmacology Review for 2024: Opioids, Sinusitis, Asthma, COPD, Hypertension and Hyperlipidemia

Stay current with the latest pharmacology guidelines across therapeutic areas with this free curriculum


CME Information

3.25 AMA PRA Category 1 Credits™, 3.25 ABIM MOC or 3.69 AANP, 3.69 AANP Pharm

Release Date: 12/19/2023

Available for credit until 12/18/2024

Learning Objectives

  • Outline guideline recommendations for prescribing opioids and available tools for safe opioid prescribing 
  • Review the diagnosis of opioid use disorder (OUD) and understand the indications and prescribing information for buprenorphine in OUD 
  • Review risks of opioid use during pregnancy  
  • Outline recommended guidelines for tapering opioids  
  • Discuss how to approach the use of cannabis by patients also using opioids long term 
  • Interpret results of a urine drug test as part of pain management contract  
  • Differentiate between the symptoms of acute rhinosinusitis versus acute bacterial rhinosinusitis/acute bacterial sinusitis. 
  • Construct an appropriate treatment plan for acute bacterial rhinosinusitis in the adult population and acute bacterial sinusitis in the pediatric population 
  • Review the definitions and clinical presentation of asthma and COPD and outline guideline-recommended treatments  
  • Review recommended treatments for dyslipidemia, describe the components of the lipid panel, and discuss management of musculoskeletal side effects for patients taking statins 
  • Outline recommended practice guidelines and review available pharmacological options for managing hypertension in the outpatient clinical setting